Direct genetic modulation of enzymes affecting the ceramide pathways in mice like dihydroceramide desaturase 1 may drive insulin resistance and hepatic steatosis (Chaurasia et al, 2019). The gene discussed is DEGS1; the disease is fatty liver disease.